4.7 Article

Gestational Weight Gain and Fetal-Maternal Adiponectin, Leptin, and CRP: results of two birth cohorts studies

Journal

Scientific Reports
Volume 7, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/srep41847

Keywords

-

Funding

  1. German Research Council [BR 1704/3-1, BR 1704/3-2, BR 1704/3-3]
  2. Medical Faculty of Ulm University

Ask authors/readers for more resources

Gestational weight gain (GWG) is an important modifiable factor known to influence fetal outcomes including birth weight and adiposity. Unlike behaviors such as smoking and alcohol consumption, the effect of GWG throughout pregnancy on fetal development and other outcomes has not been extensively studied. The aim of this study was to investigate the relationship of GWG with endocrine factors such as adiponectin, leptin, and C-reactive protein which may be associated with inflammatory response, fetal growth, and adiposity later in life. Data were obtained from the Ulm Birth Cohort Study (UBCS) and the Ulm SPATZ Health Study, two methodologically similar birth cohort studies including newborns and their mothers recruited from 11/2000-11/2001 and 04/2012-05/2013. In the two included birth cohorts we consistently observed statistically significant positive associations between GWG beginning as early as the second trimester with fetal cord blood leptin and stronger association beginning as early as the first trimester with post-delivery maternal serum leptin. Total weight gain exceeding commonly accepted recommended guidelines was consistently associated with higher leptin levels in both cord blood and post-delivery maternal serum. These results suggest a potential pathomechanistic link between fetal environment and surrogate markers of long-term health.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biology

CASANOVA: Permutation inference in factorial survival designs

Marc Ditzhaus, Jon Genuneit, Arnold Janssen, Markus Pauly

Summary: We propose inference procedures for general factorial designs with time-to-event endpoints, which allows working without restrictive model assumptions as proportional hazards and can detect the crossing points of survival or hazard curves.

BIOMETRICS (2023)

Review Pediatrics

Diversity and trends of human milk banking: a scoping review from 1946 to 2021

Linda P. Siziba, Sebastian Huhn, Elisabeth Puetz, Caroline Baier, Raphael S. Peter, Corinna Gebauer, Samantha Griffin, Sophie Wedekind, Natalie Shenker, Jon Genuneit

Summary: This scoping review provides an overview of the current state and emerging trends in donor human milk banking. The predominant topics identified were milk type and composition, and there is a lack of research on the associations between different milk types and infant outcomes. Further research is needed to explore the appropriateness of different funding sources and to foster collaborations between academics, clinicians, and milk banks in low-income or middle-income countries to improve access to donor human milk.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2023)

Review Public, Environmental & Occupational Health

Is the association of overweight and obesity with colorectal cancer underestimated? An umbrella review of systematic reviews and meta-analyses

Marko Mandic, Hengjing Li, Fatemeh Safizadeh, Tobias Niedermaier, Michael Hoffmeister, Hermann Brenner

Summary: This study aimed to assess if and to what extent potential bias from prediagnostic weight loss has been considered in available epidemiological evidence on the BMI-CRC association. After searching for systematic reviews and meta-analyses, it was found that none of them thoroughly considered or discussed prediagnostic weight loss as a potential source of bias. Results from individual cohort studies included in the latest review were reported heterogeneously, but effect estimates mostly increased with increasing length of exclusion of initial years of follow-up. The impact of overweight and obesity on CRC risk may be larger than suggested by the existing epidemiological evidence.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2023)

Article Oncology

Overall and age-specific risk advancement periods of colorectal cancer for men vs women: Implications for gender-sensitive screening offers?

Xuechen Chen, Thomas Heisser, Rafael Cardoso, Michael Hoffmeister, Hermann Brenner

Summary: Colorectal cancer (CRC) has higher incidence and mortality rates in men compared to women. A study estimated the risk advancement periods (RAPs) for men compared to women to determine at what age men reach comparable levels of risk. The results showed that men had significantly higher CRC risk in the age groups 50-59 and 60-69, with RAPs as high as 8.7 and 6.2 years earlier, respectively. This suggests the need for gender-specific screening starting ages in countries where screening starts above age 50.

INTERNATIONAL JOURNAL OF CANCER (2023)

Review Oncology

The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer

Daniele Campa, Manuel Gentiluomo, Angelika Stein, Mateus Nobrega Aoki, Martin Oliverius, Ludmila Vodickova, Krzysztof Jamroziak, George Theodoropoulos, Claudio Pasquali, William Greenhalf, Paolo Giorgio Arcidiacono, Faik Uzunoglu, Raffaele Pezzilli, Claudio Luchini, Marta Puzzono, Martin Loos, Matteo Giaccherini, Verena Katzke, Andrea Mambrini, Edita Kiudeliene, Kauffmann Emanuele Federico, Julia Johansen, Tamas Hussein, Beatrice Mohelnikova-Duchonova, Casper H. J. van Eijck, Hermann Brenner, Riccardo Farinella, Juan Sainz Perez, Martin Lovecek, Markus W. Buechler, Viktor Hlavac, Jakob R. Izbicki, Thilo Hackert, Roger Chammas, Alessandro Zerbi, Rita Lawlor, Alessio Felici, Mara Goetz, Gabriele Capurso, Laura Ginocchi, Maria Gazouli, Juozas Kupcinskas, Giulia Martina Cavestro, Pavel Vodicka, Stefania Moz, John P. Neoptolemos, Lumir Kunovsky, Stig E. Bojesen, Silvia Carrara, Domenica Gioffreda, Egidijus Morkunas, Olga Abian, Stefania Bunduc, Daniela Basso, Ugo Boggi, Barbara Wlodarczyk, Andrea Szentesi, Giuseppe Vanella, Inna Chen, Maarten F. Bijlsma, Vytautas Kiudelis, Stefano Landi, Ben Schoettker, Chiara Corradi, Nathalia Giese, Rudolf Kaaks, Giulia Peduzzi, Peter Hegyi, Luca Morelli, Niccolo Furbetta, Pavel Soucek, Anna Latiano, Renata Talar-Wojnarowska, Sidsel C. Lindgaard, Frederik Dijk, Anna Caterina Milanettoj, Francesca Tavano, Klara Cervena, Balint Eross, Sabrina G. Testoni, Judith H. E. Verhagen-Oldenampsen, E. Malecka-Wojciesko, Eithne Costello, Roberto Salvia, Evaristo Maiello, Stefano Ermini, Cosimo Sperti, Bernd Holleczek, Francesco Perri, Jurgita Skieceviciene, Livia Archibugi, Maurizio Lucchesi, Cosmeri Rizzato, Federico Canzian

Summary: Pancreatic cancer is a deadly disease with few known risk factors and susceptibility loci. The rarity of the disease and lack of adequate research power have hindered progress in understanding its genetic mechanisms. However, the PANDoRA consortium, the largest in Europe, has made significant contributions in discovering susceptibility loci, which will be crucial in developing preventive strategies.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2023)

Article Cardiac & Cardiovascular Systems

SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe

Lisa Pennells, Stephen Kaptoge, Helena Bleken Ostergaard, Stephanie H. Read, Fabrizio Carinci, Josep Franch-Nadal, Carmen Petitjean, Owen Taylor, Steven H. J. Hageman, Zhe Xu, Fanchao Shi, Sarah Spackman, Stefano Gualdi, Naomi Holman, Rui Bebiano Da Providencia E Costa, Fabrice Bonnet, Hermann Brenner, Richard F. Gillum, Stefan Kiechl, Deborah A. Lawlor, Louis Potier, Ben Schoettker, Reecha Sofat, Henry Voelzke, Johann Willeit, Zane Baltane, Stephen Fava, Sandor Janos, Astrid Lavens, Santa Pildava, Tamara Poljicanin, Ivan Pristas, Peter Rossing, Reiff Sascha, Christa Scheidt-Nave, Iztok Stotl, Gail Tibor, Vilma Urbancic-Rovan, An-Sofie Vanherwegen, Dorte Vistisen, Yong Du, Matthew R. Walker, Peter Willeit, Brian Ference, Dirk De Bacquer, Martin Halle, Radu Huculeci, John William McEvoy, Adam Timmis, Panagiotis Vardas, Jannick A. N. Dorresteijn, Ian Graham, Angela Wood, Bjorn Eliasson, William Herrington, John Danesh, Didac Mauricio, Massimo Massi Benedetti, Naveed Sattar, Frank L. J. Visseren, Sarah Wild, Emanuele Di Angelantonio, Beverley Balkau, Frederic Fumeron, Hannah Stocker, Bernd Holleczek, Sabine Schipf, Carsten Oliver Schmidt, Marcus Doerr, Herbert Tilg, Christoph Leitner, Marlene Notdurfter, Julie Taylor, Caroline Dale, David Prieto-Merino, Richard F. Gillum, Tamara Buble, Pero Ivanko, Bendix Carstensen, Christin Heidemann, Tibor Gall, Janos Sandor, Jana Lepiksone, Caroline J. Magri, Joseph Azzopardi, Jordi Real, Bogdan Vlacho, Manel Mata-Cases

Summary: The study aimed to develop and validate a recalibrated prediction model (SCORE2-Diabetes) for estimating the 10-year risk of cardiovascular disease (CVD) in individuals with type 2 diabetes in Europe. The model showed good discrimination and improvement over previous models, with risk predictions varying based on individuals' diabetes-related factors. SCORE2-Diabetes enhances the identification of individuals at higher risk of CVD in Europe.

EUROPEAN HEART JOURNAL (2023)

Article Public, Environmental & Occupational Health

About the associations of vitamin D deficiency and biomarkers of systemic inflammatory response with all-cause and cause-specific mortality in a general population sample of almost 400,000 UK Biobank participants

Sha Sha, Tafirenyika Gwenzi, Li-Ju Chen, Hermann Brenner, Ben Schoettker

Summary: This study investigated the interrelationships between vitamin D deficiency, biomarkers of systemic inflammation response (SIR), and mortality. It found that vitamin D deficiency was associated with disadvantageous levels of blood cell count-based SIR biomarkers, but not with C-reactive protein (CRP)-based biomarkers. Vitamin D deficiency and all SIR biomarkers were significantly associated with all-cause mortality and mortality from cancer, cardiovascular, and respiratory disease. The study suggests that clinical interventions targeting both vitamin D deficiency and underlying causes of systemic inflammation may be beneficial.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2023)

Article Multidisciplinary Sciences

Learning high-order interactions for polygenic risk prediction

Michela C. Massi, Nicola R. Franco, Andrea Manzoni, Anna Maria Paganoni, Hanla A. Park, Michael Hoffmeister, Hermann Brenner, Jenny Chang-Claude, Francesca Ieva, Paolo Zunino

Summary: Within the precision medicine framework, the stratification of individual genetic susceptibility based on inherited DNA variation is crucial. Traditional Polygenic Risk Scores (PRS) approaches face challenges in modeling complex high-order non-linear SNP-SNP interactions and their effect on the phenotype. In this study, we propose a novel approach called High-order Interactions-aware Polygenic Risk Score (hiPRS), which incorporates high-order interactions and provides a simple and interpretable model. Through comprehensive simulations and real data analysis, hiPRS demonstrates superior performance in scoring and interpretability compared to state of the art methods.

PLOS ONE (2023)

Letter Oncology

A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment

Tobias Niedermaier, Elizabeth Alwers, Xuechen Chen, Thomas Heisser, Michael Hoffmeister, Hermann Brenner

CANCER COMMUNICATIONS (2023)

Article Cell Biology

Generalizable biomarker prediction from cancer pathology slides with self-supervised deep learning: A retrospective multi-centric study

Jan Moritz Niehues, Philip Quirke, Nicholas P. West, Heike I. Grabsch, Marko van Treeck, Yoni Schirris, Gregory P. Veldhuizen, Gordon G. A. Hutchins, Susan D. Richman, Sebastian Foersch, Titus J. Brinker, Junya Fukuoka, Andrey Bychkov, Wataru Uegami, Daniel Truhn, Hermann Brenner, Alexander Brobeil, Michael Hoffmeister, Jakob Nikolas Kather

Summary: Deep learning can predict microsatellite instability (MSI) from routine histopathology slides of colorectal cancer (CRC). It is unclear whether DL can also predict other biomarkers with high performance and whether DL predictions generalize to external patient populations.

CELL REPORTS MEDICINE (2023)

Article Oncology

Benefit finding, posttraumatic growth and health-related quality of life in long-term cancer survivors: a prospective population-based study

Zhunzhun Liu, Melissa S. Y. Thong, Daniela Doege, Lena Koch-Gallenkamp, Linda Weisser, Heike Bertram, Andrea Eberle, Bernd Holleczek, Alice Nennecke, Annika Waldmann, Sylke Ruth Zeissig, Ron Pritzkuleit, Hermann Brenner, Volker Arndt

Summary: This study explores the relationship between benefit finding/posttraumatic growth and health-related quality of life in long-term cancer survivors. The results show that lower levels of benefit finding are associated with better quality of life, while posttraumatic growth is associated with role functioning and global health status/quality of life. These findings provide further evidence that benefit finding and posttraumatic growth are two distinct positive psychological concepts.

ACTA ONCOLOGICA (2023)

Review Computer Science, Artificial Intelligence

Machine learning in the identification of prognostic DNA methylation biomarkers among patients with cancer: A systematic review of epigenome-wide studies

Tanwei Yuan, Dominic Edelmann, Ziwen Fan, Elizabeth Alwers, Jakob Nikolas Kather, Hermann Brenner, Michael Hoffmeister

Summary: This systematic review discusses the use of machine learning in epigenome-wide studies for identifying DNA methylation biomarkers associated with cancer prognosis. The study reveals that there is a lack of performance evaluation and methodological flaws in the current approaches.

ARTIFICIAL INTELLIGENCE IN MEDICINE (2023)

Article Oncology

A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

Pooja K. Middha, Xiaoliang Wang, Sabine Behrens, Manjeet K. Bolla, Qin Wang, Joe Dennis, Kyriaki Michailidou, Thomas U. Ahearn, Irene L. Andrulis, Hoda Anton-Culver, Volker Arndt, Kristan J. Aronson, Paul L. Auer, Annelie Augustinsson, Thais Baert, Laura E. Beane Freeman, Heiko Becher, Matthias W. Beckmann, Javier Benitez, Stig E. Bojesen, Hiltrud Brauch, Hermann Brenner, Angela Brooks-Wilson, Daniele Campa, Federico Canzian, Angel Carracedo, Jose E. Castelao, Stephen J. Chanock, Georgia Chenevix-Trench, Emilie Cordina-Duverger, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Laure Dossus, Pierre-Antoine Dugue, A. Heather Eliassen, Mikael Eriksson, D. Gareth Evans, Peter A. Fasching, Jonine Figueroa, Olivia Fletcher, Henrik Flyger, Marike Gabrielson, Manuela Gago-Dominguez, Graham G. Giles, Anna Gonzalez-Neira, Felix Grassmann, Anne Grundy, Pascal Guenel, Christopher A. Haiman, Niclas Hakansson, Per Hall, Ute Hamann, Susan E. Hankinson, Elaine F. Harkness, Bernd Holleczek, Reiner Hoppe, John L. Hopper, Richard S. Houlston, Anthony Howell, David J. Hunter, Christian Ingvar, Karolin Isaksson, Helena Jernstroem, Esther M. John, Michael E. Jones, Rudolf Kaaks, Renske Keeman, Cari M. Kitahara, Yon-Dschun Ko, Stella Koutros, Allison W. Kurian, James V. Lacey, Diether Lambrechts, Nicole L. Larson, Susanna Larsson, Loic Le Marchand, Flavio Lejbkowicz, Shuai Li, Martha Linet, Jolanta Lissowska, Maria Elena Martinez, Tabea Maurer, Anna Marie Mulligan, Claire Mulot, Rachel A. Murphy, William G. Newman, Sune F. Nielsen, Borge G. Nordestgaard, Aaron Norman, Katie M. O'Brien, Janet E. Olson, Alpa V. Patel, Ross Prentice, Erika Rees-Punia, Gad Rennert, Valerie Rhenius, Kathryn J. Ruddy, Dale P. Sandler, Christopher G. Scott, Mitul T. Shah, Xiao-Ou Shu, Ann Smeets, Melissa C. Southey, Jennifer Stone, Rulla M. Tamimi, Jack A. Taylor, Lauren R. Teras, Katarzyna Tomczyk, Melissa A. Troester, Therese Truong, Celine M. Vachon, Sophia S. Wang, Clarice R. Weinberg, Hans Wildiers, Walter Willett, Stacey J. Winham, Alicja Wolk, Xiaohong Yang, M. Pilar Zamora, Wei Zheng, Argyrios Ziogas, Alison M. Dunning, Paul D. P. Pharoah, Montserrat Garcia-Closas, Marjanka K. Schmidt, Peter Kraft, Roger L. Milne, Sara Lindstroem, Douglas F. Easton, Jenny Chang-Claude

Summary: A genome-wide study identified two independent SNP-risk factor pairs associated with breast cancer risk and estrogen receptor positive (ER +) breast cancer risk. Overall, gene-environment interactions have a very small contribution to the heritability of breast cancer. At the population level, these interactions do not significantly contribute to risk prediction for breast cancer.

BREAST CANCER RESEARCH (2023)

Article Cardiac & Cardiovascular Systems

Agreement among high-sensitivity cardiac troponin assays and non-invasive testing, clinical outcomes, and quality-of-care outcomes based on the 2020 European Society of Cardiology Guidelines

Julia Karady, Thomas Mayrhofer, James L. Januzzi, James E. Udelson, Jerome L. Fleg, Bela Merkely, Michael T. Lu, William F. Peacock, John T. Nagurney, Wolfgang Koenig, Maros Ferencik, Udo Hoffmann

Summary: This study aimed to determine the concordance of different high-sensitivity cardiac troponin (hs-cTn) assays in risk stratification for cardiovascular disease and compare the differences in patient management, cost, and predicted quality of care.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2023)

No Data Available